M
MiCo BioMed Co Ltd
KOSDAQ:214610
MiCo BioMed Co Ltd
KOSDAQ:214610
Price:
2 290
KRW
-2.35%
Market Closed
Market Cap:
₩19.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
MiCo BioMed Co Ltd
KOSDAQ:214610
|
KR |
Multiples-Based Value
The Multiples-Based Value for MiCo BioMed Co Ltd (214610) under the Base Case is 2 754.42 KRW. Compared with the current market price of 2 290 KRW, the stock appears Undervalued by 17%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
2 754.42
KRW
Undervaluation 17%
M
Multiples Across Competitors
Competitors Multiples
MiCo BioMed Co Ltd Competitors
MiCo BioMed Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
M
|
MiCo BioMed Co Ltd
KOSDAQ:214610
|
19.2B KRW | 4.8 | -1.4 | -1.6 | -1.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
177.7B USD | 4 | 27.3 | 15.7 | 21.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.7B USD | 15.9 | 56 | 42.4 | 52.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.1B USD | 5 | 39 | 20 | 24.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.7B USD | 3.1 | 24.1 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
92.8B USD | 4.5 | 31.3 | 18.6 | 25 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.1B USD | 7.7 | 43.7 | 24 | 26.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.6B EUR | 1.7 | 19.2 | 10.8 | 15.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46B USD | 10.6 | 43.1 | 30.5 | 33.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.2B USD | 2 | 25.1 | 10 | 16.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.8B USD | 6 | 22 | 15.4 | 17.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
